Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20265 Citations
Beginner, moderate, and aggressive dosing amounts with timing. Free, no signup.
Deep subcutaneous (upper outer quadrant of buttock)
Lanreotide (Somatuline Depot) has no standard bacteriostatic water volume on file, so there are no syringe units to calculate here. Dosing runs 60mg to 120mg per administration, every 4 weeks. A 60mg supply covers about 1 dose at the beginner tier.
If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.
Lanreotide is an FDA-approved somatostatin analog given once every 28 days for acromegaly and GEP-NETs. The CLARINET trial showed 53% reduced progression risk; PRIMARYS found 63% of patients had tumor shrinkage by 48 weeks. Pre-filled syringe, no reconstitution. GI side effects and gallstone risk require monitoring.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 60mg | Every 4 weeks |
| Moderate | 90mg | Every 4 weeks |
| Aggressive | 120mg | Every 4 weeks |
Lanreotide is different from most peptides on this platform. There is no vial to reconstitute, no bacteriostatic water, no insulin syringe math. It arrives as a pre-filled syringe in three strengths: 60 mg (0.3 mL), 90 mg (0.3 mL), and 120 mg (0.5 mL). You inject the full contents. That's it. The catch is that this is a deep subcutaneous injection into the upper outer quadrant of the buttock, not a typical belly or thigh pinch. Many patients have a healthcare provider do it, at least initially. Cold chain matters. Store at 2 to 8 degrees Celsius. Pull the syringe out 30 minutes before injection to reach room temperature; cold gel is thicker and harder to push through the needle. One thing beginners miss: GI side effects in the first month are not a sign that something went wrong. They are expected. Low-fat meals (under 40 g/day) and pancreatic enzyme supplements help considerably. Alternate left and right buttock each month. Superficial injection worsens nodule formation.
Dosing based on Somatuline Depot (lanreotide) FDA Prescribing Information (2024) — 7 published references.View all sources →
Cross-check your Lanreotide (Somatuline Depot) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.